Dosage and Route of Administration of Neuroleptic Drugs During Different Phases of a Schizophrenic Illness
Maintenance antipsychotic drug treatment has proven to be of enormous value in preventing psychotic relapse and rehospitalization, as well as in setting the stage for optimal vocational and psychosocial adjustment in patients with schizophrenia. Numerous double-blind, placebo-controlled trials support these conclusions, and several review articles have appeared in recent years summarizing their findings (Davis et al. 1980; Kane and Lieberman 1987).
KeywordsPlacebo Titration Schizophrenia Hydrochloride Haloperidol
Unable to display preview. Download preview PDF.
- Hogarty GE, Schooler NR, Ulrich RF, Mussare F, Ferro P, Herron E (1979) Fluphenazine and social therapy in the aftercare of schizophrenic patients: relapse analysis of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride. Arch Gen Psychiatry 36:1283–1294PubMedCrossRefGoogle Scholar
- Kane JM, Lieberman JA (1987) Maintenance pharmacotherapy in schizophrenia. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven, New York, pp 1103–1109Google Scholar
- McEvoy JP, Hogerty GE, Steingard S (1990) Optimal dose of neuroleptics in acute schizophrenia: a controlled study of the neuroleptic threshold. (Submitted for publication)Google Scholar
- Weiden PJ, Mann JJ, Haas G, Mattson M, Francis A (1986) Clinical nonrecognition of drug-induced movement disorders: a cautionary study. Annual Meeting of the American Psychiatric Association, May, WashingtonGoogle Scholar